Rescue of neurological deficits in a mouse model for Angelman syndrome by reduction of αCaMKII inhibitory phosphorylation
Open accessThe DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Abstract
Angelman syndrome (AS) is a severe neurological disorder characterized by mental retardation, motor dysfunction and epilepsy. We show that the molecular and cellular deficits of an AS mouse model can be rescued by introducing an additional mutation at the inhibitory phosphorylation site of alphaCaMKII. Moreover, these double mutants no longer show the behavioral deficits seen in AS mice, suggesting that these deficits are the direct result of increased inhibitory phosphorylation of alphaCaMKII.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Several mouse models of ASD, including those of Rett syndrome96,97, Angelman syndrome98, tuberous sclerosis complex71, and Fragile X23 syndrome, and mouse models of rare mutations in SHANK proteins49, have provided convincing evidence that ASD phenotypes can be improved by genetic or pharmacological interventions”
From Activity-dependent neuronal signalling and autism spectrum disorder (2013) · cites this paper as [98]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
UBE3A/E6-AP mutations cause Angelman syndrome
Kishino, T., Lalande, M., & Wagstaff, J. (1997) · Nature Genetics · doi:10.1038/ng0197-70 · Cited by 1,298
De novo truncating mutations in E6-AP ubiquitin-protein ligase gene (UBE3A) in Angelman syndrome
Matsuura, T., Sutcliffe, J. S., Fang, P., Galjaard, R.-J., Jiang, Y.-H., Benton, C. S., Rommens, J. M., & Beaudet, A. L. (1997) · Nature Genetics · doi:10.1038/ng0197-74 · Cited by 856
Self-citationJiang, Y.-H., Armstrong, D., Albrecht, U., Atkins, C. M., Noebels, J. L., Eichele, G., Sweatt, J. D., & Beaudet, A. L. (1998) · Neuron · doi:10.1016/s0896-6273(00)80596-6 · Cited by 852
Self-citationAlbrecht, U., Sutcliffe, J. S., Cattanach, B. M., Beechey, C. V., Armstrong, D., Eichele, G., & Beaudet, A. L. (1997) · Nature Genetics · doi:10.1038/ng0997-75 · Cited by 583
Knoll, J. H. M., Nicholls, R. D., Magenis, R. E., Graham, J. M., Lalande, M., Latt, S. A., Opitz, J. M., & Reynolds, J. F. (1989) · American Journal of Medical Genetics · doi:10.1002/ajmg.1320320235 · Cited by 576
Inhibitory Autophosphorylation of CaMKII Controls PSD Association, Plasticity, and Learning
Elgersma, Y., Fedorov, N. B., Ikonen, S., Choi, E. S., Elgersma, M., Carvalho, O. M., Giese, K. P., & Silva, A. J. (2002) · Neuron · doi:10.1016/s0896-6273(02)01007-3 · Cited by 290
Self-citationWeeber, E. J., Jiang, Y.-H., Elgersma, Y., Varga, A. W., Carrasquillo, Y., Brown, S. E., Christian, J. M., Mirnikjoo, B., Silva, A., Beaudet, A. L., et al. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-07-02634.2003 · Cited by 264
Self-citationClayton‐Smith, J. (1993) · American Journal of Medical Genetics · doi:10.1002/ajmg.1320460105 · Cited by 247
αCaMKII Is Essential for Cerebellar LTD and Motor Learning
Hansel, C., de Jeu, M., Belmeguenai, A., Houtman, S. H., Buitendijk, G. H. S., Andreev, D., De Zeeuw, C. I., & Elgersma, Y. (2006) · Neuron · doi:10.1016/j.neuron.2006.08.013 · Cited by 230
Self-citationElgersma, Y., Sweatt, J. D., & Giese, K. P. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.3622-04.2004 · Cited by 148
Self-citation
Cited by
Items 101–200 of 277
Cramer, N., & Galdzicki, Z. (2012) · Neural Plasticity · doi:10.1155/2012/101542 · Cited by 54
Conformational changes underlying calcium/calmodulin‐dependent protein kinase II activation
Hoffman, L., Stein, R. A., Colbran, R. J., & Mchaourab, H. S. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.40 · Cited by 54
“…(2011) 30, 1251–1262 | & 2011 European Molecular Biology Organization | All Rights Reserved 0261-4189/11 www.embojournal.org &2011 European Molecular Biology Organization The EMBO Journal VOL 30 | NO 7 | 2011 EMBO THE JOURNAL 1251 Thr305/306 autophosphorylation sites (van Woerden et al, 2007).”
BackgroundRoxrud, I., Raiborg, C., Gilfillan, G. D., Strømme, P., & Stenmark, H. (2009) · Experimental Cell Research · doi:10.1016/j.yexcr.2009.07.012 · Cited by 59
Understanding the Pathogenesis of Angelman Syndrome through Animal Models
Jana, N. R. (2012) · Neural Plasticity · doi:10.1155/2012/710943 · Cited by 56
Fragile x syndrome and autism: from disease model to therapeutic targets
Dölen, G., & Bear, M. F. (2009) · Journal of Neurodevelopmental Disorders · doi:10.1007/s11689-009-9015-x · Cited by 51
Guo, W., Ceolin, L., Collins, K. A., Perroy, J., & Huber, K. M. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.11.013 · Cited by 50
Angelman syndrome: Current and emerging therapies in 2016
Tan, W., & Bird, L. M. (2016) · American Journal of Medical Genetics Part C Seminars in Medical Genetics · doi:10.1002/ajmg.c.31536 · Cited by 55
Farook, M. F., DeCuypere, M. G., Hyland, Κ., Takumi, T., LeDoux, M. S., & Reiter, L. T. (2012) · PLoS ONE · doi:10.1371/journal.pone.0043030 · Cited by 52
Martínez-Noël, G., Luck, K., Kühnle, S., Desbuleux, A., Szajner, P., Galligan, J. T., Rodriguez, D., Zheng, L., Boyland, K. A., Leclere, F., et al. (2018) · Journal of Molecular Biology · doi:10.1016/j.jmb.2018.01.021 · Cited by 61
Adhikari, A., Copping, N. A., Beegle, J. R., Cameron, D. L., Deng, P., O’Geen, H., Segal, D. J., Fink, K. D., Silverman, J. L., & Anderson, J. S. (2021) · Human Molecular Genetics · doi:10.1093/hmg/ddab104 · Cited by 58
Kawaguchi, S., & Hirano, T. (2013) · The Journal of Physiology · doi:10.1113/jphysiol.2012.245787 · Cited by 54
Mardirossian, S., Rampon, C., Salvert, D., Fort, P., & Sarda, N. (2009) · Experimental Neurology · doi:10.1016/j.expneurol.2009.08.035 · Cited by 53
Subcellular organization of UBE3A in human cerebral cortex
Burette, A. C., Judson, M. C., Li, A. N., Chang, E. F., Seeley, W. W., Philpot, B. D., & Weinberg, R. J. (2018) · Molecular Autism · doi:10.1186/s13229-018-0238-0 · Cited by 54
Subcellular organization of UBE3A in neurons
Burette, A. C., Judson, M. C., Burette, S., Phend, K. D., Philpot, B. D., & Weinberg, R. J. (2017) · Journal of Comparative Neurology · doi:10.1002/cne.24063 · Cited by 46
The HECT E3 Ligase E6AP/UBE3A as a Therapeutic Target in Cancer and Neurological Disorders
Owais, A., Mishra, R. K., & Kiyokawa, H. (2020) · Cancers · doi:10.3390/cancers12082108 · Cited by 53
Dissociation of locomotor and cerebellar deficits in a murine Angelman syndrome model
Bruinsma, C. F., Schonewille, M., Gao, Z., Aronica, E., Judson, M. C., Philpot, B. D., Hoebeek, F. E., van Woerden, G. M., Zeeuw, C. I. D., & Elgersma, Y. (2015) · Journal of Clinical Investigation · doi:10.1172/jci83541 · Cited by 48
Self-citationDelta power robustly predicts cognitive function in Angelman syndrome
Ostrowski, L. M., Spencer, E. R., Bird, L. M., Thibert, R. L., Komorowski, R. W., Kramer, M., & Chu, C. J. (2021) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.51385 · Cited by 48
Judson, M. C., Shyng, C., Simon, J. M., Davis, C. R., Punt, A. M., Salmon, M. T., Miller, N. W., Ritola, K., Elgersma, Y., Amaral, D. G., et al. (2021) · JCI Insight · doi:10.1172/jci.insight.144712 · Cited by 50
Self-citationOliver, C., Adams, D., Allen, D., Bull, L., Heald, M., Moss, J. F., Wilde, L., & Woodcock, K. A. (2013) · International review of research in developmental disabilities · doi:10.1016/b978-0-12-401662-0.00006-3 · Cited by 50
Reelin Signaling in Neurodevelopmental Disorders and Neurodegenerative Diseases
Joly‐Amado, A., Kulkarni, N., & Nash, K. R. (2023) · Brain Sciences · doi:10.3390/brainsci13101479 · Cited by 51
Long, J., Li, H., Liu, Y., Liao, X., Tang, Z., Han, K., Chen, J., & Zhang, H. (2024) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1364858 · Cited by 49
Zeng, F., Ma, X., Zhu, L., Xu, Q., Zeng, Y., Gao, Y., Li, G., Guo, T., Zhang, H., Tang, X., et al. (2019) · PLOS Biology · doi:10.1371/journal.pbio.3000525 · Cited by 43
Epigenetics and Neural Developmental Disorders
Zhao, X., Pak, C., Smrt, R. D., & Jin, P. (2007) · Epigenetics · doi:10.4161/epi.2.2.4236 · Cited by 52
Ciarlone, S. L., Wang, X., Rogawski, M. A., & Weeber, E. J. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.12.009 · Cited by 46
Self-citationJudson, M. C., Burette, A. C., Thaxton, C. L., Pribisko, A. L., Shen, M. D., Rumple, A. M., Del Cid, W. A., Paniagua, B., Styner, M., Weinberg, R. J., et al. (2017) · The Journal of Neuroscience · doi:10.1523/jneurosci.0037-17.2017 · Cited by 42
Emerging Gene and Small Molecule Therapies for the Neurodevelopmental Disorder Angelman Syndrome
Copping, N. A., McTighe, S. M., Fink, K. D., & Silverman, J. L. (2021) · Neurotherapeutics · doi:10.1007/s13311-021-01082-x · Cited by 45
Using genetic findings in autism for the development of new pharmaceutical compounds
Vorstman, J. A. S., Spooren, W., Persico, A. M., Collier, D. A., Aigner, S., Jagasia, R., Glennon, J. C., & Buitelaar, J. K. (2014) · Psychopharmacology · doi:10.1007/s00213-013-3334-z · Cited by 38
Schreiber, J., Grimbergen, L.-A., Overwater, I. E., van der Vaart, T., Stedehouder, J., Schuhmacher, A. J., Guerra, C. E., Kushner, S. A., Jaarsma, D., & Elgersma, Y. (2017) · Scientific Reports · doi:10.1038/s41598-017-01218-0 · Cited by 39
Self-citationBerkowitz, B. A., Lenning, J. C., Khetarpal, N., Tran, C., Wu, J. Y., Berri, A. M., Dernay, K., Haacke, E. M., Khorassani, F. S., Podolsky, R. H., et al. (2017) · The FASEB Journal · doi:10.1096/fj.201700229r · Cited by 38
Neural and behavioral epigenetics; what it is, and what is hype
Isles, A. R. (2015) · Genes, Brain and Behavior · doi:10.1111/gbb.12184 · Cited by 37
Koyavski, L., Panov, J., Simchi, L., Rayi, P. R., Sharvit, L. E., Feuermann, Y., & Kaphzan, H. (2019) · Molecular Neurobiology · doi:10.1007/s12035-019-1503-8 · Cited by 37
The neuronal ubiquitin-proteasome system: Murine models and their neurological phenotype
van Tijn, P., Hol, E. M., van Leeuwen, F. W., & Fischer, D. F. (2008) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2008.03.001 · Cited by 39
An essential role for UBE2A/HR6A in learning and memory and mGLUR-dependent long-term depression
Bruinsma, C. F., Savelberg, S. M. C., Kool, M. J., Jolfaei, M. A., van Woerden, G. M., Baarends, W. M., & Elgersma, Y. (2015) · Human Molecular Genetics · doi:10.1093/hmg/ddv436 · Cited by 35
Self-citationAutism throughout genetics: Perusal of the implication of ion channels
Daghsni, M., Rima, M., Fajloun, Z., Ronjat, M., Brusés, J. L., Mrad, R., & WAARD, M. M. D. (2018) · Brain and Behavior · doi:10.1002/brb3.978 · Cited by 37
Upadhyay, A., Amanullah, A., Chhangani, D., Mishra, R., & Mishra, A. (2015) · Ageing Research Reviews · doi:10.1016/j.arr.2015.07.009 · Cited by 35
Enhanced Transmission at the Calyx of Held Synapse in a Mouse Model for Angelman Syndrome
Wang, T., van Woerden, G. M., Elgersma, Y., & Borst, J. G. G. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2017.00418 · Cited by 35
Self-citationDosage-sensitive genes in autism spectrum disorders: From neurobiology to therapy
Javed, S., Selliah, T., Lee, Y., & Huang, W. (2020) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2020.08.009 · Cited by 36
Gene Transfer Therapy for Neurodevelopmental Disorders
Özlü, C., Bailey, R. M., Sinnett, S. E., & Goodspeed, K. (2021) · Developmental Neuroscience · doi:10.1159/000515434 · Cited by 34
The Angelman Syndrome Protein Ube3A Regulates Synapse Development by Ubiquitinating Arc
Greer, P. L., Hanayama, R., Bloodgood, B. L., Mardinly, A. R., Lipton, D. M., Flavell, S. W., Kim, T.-K., Griffith, E. C., Waldon, Z., Maehr, R., et al. (2010) · Cell · doi:10.1016/j.cell.2010.01.026 · Cited by 30
Autism-like behavior caused by deletion of vaccinia-related kinase 3 is improved by TrkB stimulation
Kang, M.-S., Choi, T.-Y., Ryu, H. G., Lee, D., Lee, S., Choi, S., & Kim, K. (2017) · The Journal of Experimental Medicine · doi:10.1084/jem.20160974 · Cited by 30
A randomized controlled trial of levodopa in patients with Angelman syndrome
Tan, W., Bird, L. M., Sadhwani, A., Barbieri‐Welge, R. L., Skinner, S. A., Horowitz, L. T., Bacino, C. A., Noll, L. M., Fu, C., Hundley, R. J., et al. (2017) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.38457 · Cited by 32
Self-citationRole of calcium/calmodulin-dependent kinase 2 in neurodevelopmental disorders
Onori, M. P., & van Woerden, G. M. (2021) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2021.03.014 · Cited by 34
Activity-dependent changes in MAPK activation in the Angelman Syndrome mouse model
Filonova, I., Trotter, J. H., Banko, J. L., & Weeber, E. J. (2014) · Learning & Memory · doi:10.1101/lm.032375.113 · Cited by 35
Self-citationThe prospect of molecular therapy for Angelman syndrome and other monogenic neurologic disorders
Bailus, B. J., & Segal, D. J. (2014) · BMC Neuroscience · doi:10.1186/1471-2202-15-76 · Cited by 33
Stem cells and modeling of autism spectrum disorders
Freitas, B. C. G., Trujillo, C. A., Carromeu, C., Yusupova, M., Herai, R. H., & Muotri, A. R. (2014) · Experimental Neurology · doi:10.1016/j.expneurol.2012.09.017 · Cited by 27
Potential therapeutic approaches for Angelman syndrome
Bi, X., Sun, J., Ji, A. X., & Baudry, M. (2015) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2016.1115837 · Cited by 29
UBE3A regulates the transcription of IRF, an antiviral immunity
Furumai, R., Tamada, K., Liu, X., & Takumi, T. (2019) · Human Molecular Genetics · doi:10.1093/hmg/ddz019 · Cited by 26
Novel Insights into the Role of UBE3A in Regulating Apoptosis and Proliferation
Simchi, L., Panov, J., Morsy, O., Feuermann, Y., & Kaphzan, H. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9051573 · Cited by 29
Synaptic Plasticity in Mouse Models of Autism Spectrum Disorders
Chung, L., Bey, A. L., & Jiang, Y. (2012) · Korean Journal of Physiology and Pharmacology · doi:10.4196/kjpp.2012.16.6.369 · Cited by 31
Self-citationEnhanced Operant Extinction and Prefrontal Excitability in a Mouse Model of Angelman Syndrome
Sidorov, M. S., Judson, M. C., Kim, H., Rougie, M., Ferrer, A. I., Nikolova, V. D., Riddick, N. V., Moy, S. S., & Philpot, B. D. (2018) · The Journal of Neuroscience · doi:10.1523/jneurosci.2828-17.2018 · Cited by 25
Lovastatin suppresses hyperexcitability and seizure in Angelman syndrome model
Chung, L., Bey, A. L., Towers, A. J., Cao, X., Kim, I. H., & Jiang, Y.-H. (2017) · Neurobiology of Disease · doi:10.1016/j.nbd.2017.10.016 · Cited by 28
Self-citationIshida, A., Sueyoshi, N., Shigeri, Y., & Kameshita, I. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.127 · Cited by 29
The neurobiology of mouse models syntenic to human chromosome 15q
Takumi, T. (2011) · Journal of Neurodevelopmental Disorders · doi:10.1007/s11689-011-9088-1 · Cited by 25
Proteomic Analysis of Postsynaptic Protein Complexes Underlying Neuronal Plasticity
Baucum, A. J. (2017) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.7b00008 · Cited by 27
Leach, P. T., & Crawley, J. N. (2017) · Genes Brain & Behavior · doi:10.1111/gbb.12452 · Cited by 28
Epilepsy in Children - Clinical and Social Aspects
Gadže, Ž. P. (2011) · InTech eBooks · doi:10.5772/1140 · Cited by 25
E6AP in the Brain: One Protein, Dual Function, Multiple Diseases
Hokayem, J. A. E., & Nawaz, Z. (2013) · Molecular Neurobiology · doi:10.1007/s12035-013-8563-y · Cited by 32
Gasparini, S., Vecchio, G. D., Gioiosa, S., Flati, T., Castrignanò, T., Legnini, I., Licursi, V., Ricceri, L., Scattoni, M. L., Rinaldi, A., et al. (2020) · Molecular Neurobiology · doi:10.1007/s12035-020-01878-6 · Cited by 23
Berg, E. L., Jami, S. A., Petkova, S. P., Berz, A., Fenton, T. A., Lerch, J. P., Segal, D. J., Gray, J. A., Ellegood, J., Wöhr, M., et al. (2021) · Journal of Neuroscience · doi:10.1523/jneurosci.0925-21.2021 · Cited by 24
Behavioral Evaluation of Angelman Syndrome Mice at Older Ages
Dutta, R., & Crawley, J. N. (2019) · Neuroscience · doi:10.1016/j.neuroscience.2019.10.027 · Cited by 22
Hanson, J. E., & Madison, D. V. (2010) · BMC Neuroscience · doi:10.1186/1471-2202-11-96 · Cited by 27
A PSD-95 peptidomimetic mitigates neurological deficits in a mouse model of Angelman syndrome
Lau, K. A., Yang, X., Rioult-Pedotti, M. S., Tang, S., Appleman, M., Zhang, J., Tian, Y., Marino, C., Yao, M., Jiang, Q., et al. (2023) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2023.102513 · Cited by 23
Potential for treatment of severe autism in tuberous sclerosis complex.
Gipson, T. T., Gerner, G., Wilson, M. A., Blue, M., & Johnston, M. (2013) · World Journal of Clinical Pediatrics · doi:10.5409/wjcp.v2.i3.16 · Cited by 21
Ca2+‐Dependent Hyperpolarization Pathways in Sleep Homeostasis and Mental Disorders
Shi, S., & Ueda, H. R. (2017) · BioEssays · doi:10.1002/bies.201700105 · Cited by 26
Tonazzini, I., van Woerden, G. M., Masciullo, C., Mientjes, E., Elgersma, Y., & Cecchini, M. G. (2019) · Molecular Autism · doi:10.1186/s13229-019-0293-1 · Cited by 24
Self-citationVatsa, N., Kumar, V., Singh, B. K., Kumar, R., Sharma, A., & Jana, N. R. (2019) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2019.00035 · Cited by 21
Variation in Dube3a expression affects neurotransmission at the Drosophila neuromuscular junction
Valdez, C., Scroggs, R. S., Chassen, R., & Reiter, L. T. (2015) · Biology Open · doi:10.1242/bio.20148045 · Cited by 20
Tonazzini, I., Meucci, S., van Woerden, G. M., Elgersma, Y., & Cecchini, M. G. (2016) · Advanced Healthcare Materials · doi:10.1002/adhm.201500815 · Cited by 24
Self-citationFolci, A., Mirabella, F., & Fossati, M. (2020) · eNeuro · doi:10.1523/eneuro.0137-20.2020 · Cited by 22
Sun, J., Liu, Y., Zhu, G., Cato, C., Hao, X., Qian, L., Lin, W., Adhikari, R., Luo, Y., Baudry, M., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-66790-4 · Cited by 21
Towards an understanding of Angelman syndrome in mice studies
Yang, X. (2019) · Journal of Neuroscience Research · doi:10.1002/jnr.24576 · Cited by 17
Ubiquitin-Proteasome-Mediated Protein Degradation and Disorders of the Central Nervous System
Hegde, A. N., Timm, L. E., Sivley, C. J., Ramiyaramcharankarthic, S., Lowrimore, O. J., Hendrix, B. J., Grozdanov, T. G., & Anderson, W. J. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26030966 · Cited by 19
Soeda, F., Tanaka, A., Shirasaki, T., & Takahama, K. (2010) · Neuroscience · doi:10.1016/j.neuroscience.2010.04.047 · Cited by 17
Godavarthi, S. K., Dey, P. N., Sharma, A., & Jana, N. R. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.07.103 · Cited by 17
Convergent synaptic and circuit substrates underlying autism genetic risks
McGee, A. W., Li, G., Lu, Z., & Qiu, S. (2014) · Frontiers in Biology · doi:10.1007/s11515-014-1298-y · Cited by 17
Self-citationPharmacological therapies for Angelman syndrome
Tan, W., & Bird, L. M. (2016) · Wiener Medizinische Wochenschrift · doi:10.1007/s10354-015-0408-z · Cited by 22
Moreira-de-Sá, A., Gonçalves, F. Q., Lopes, J. P., Silva, H. B. L., Tomé, Â. R., Cunha, R. A., & Canas, P. M. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.105137 · Cited by 21
Sex‐dependent influence of postweaning environmental enrichment in Angelman syndrome model mice
Cosgrove, J. A., Kelly, L. K., Kiffmeyer, E. A., & Kloth, A. D. (2022) · Brain and Behavior · doi:10.1002/brb3.2468 · Cited by 17
Tanas, J. K., Kerr, D. D., Wang, L., Rai, A., Wallaard, I., Elgersma, Y., & Sidorov, M. S. (2022) · Translational Psychiatry · doi:10.1038/s41398-022-02206-3 · Cited by 19
Self-citationAsh, R. T., Buffington, S. A., Park, J., Suter, B., Costa‐Mattioli, M., Zoghbi, H. Y., & Smirnakis, S. M. (2021) · eNeuro · doi:10.1523/eneuro.0056-21.2021 · Cited by 21
The E3 ligase ube3a is required for learning in Drosophila melanogaster
Chakraborty, M., Paul, B. K., Nayak, T., Das, A., Jana, N. R., & Bhutani, S. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.04.110 · Cited by 16
Dynamic impact of temporal context of Ca2+ signals on inhibitory synaptic plasticity
Kawaguchi, S., Nagasaki, N., & Hirano, T. (2011) · Scientific Reports · doi:10.1038/srep00143 · Cited by 15
Spaced training improves learning in Ts65Dn and Ube3a mouse models of intellectual disabilities
Lauterborn, J. C., Schultz, M. N., Le, A. A., Amani, M., Friedman, A. E., Leach, P. T., Gall, C. M., LYNCH, G. S., & Crawley, J. N. (2019) · Translational Psychiatry · doi:10.1038/s41398-019-0495-5 · Cited by 18
Spatial and temporal silencing of the human maternal UBE3A gene
Daily, J., Smith, A., & Weeber, E. J. (2012) · European Journal of Paediatric Neurology · doi:10.1016/j.ejpn.2012.03.006 · Cited by 18
Self-citationScheiffele, P., & Beg, A. A. (2010) · Nature · doi:10.1038/468907a · Cited by 22
Aberrant aggressive behavior in a mouse model of Angelman syndrome
Simchi, L., & Kaphzan, H. (2021) · Scientific Reports · doi:10.1038/s41598-020-79984-7 · Cited by 14
Syding, L. A., Kubik‐Zahorodna, A., Nickl, P., Novosadová, V., Kopkanova, J., Kašpárek, P., Procházka, J., & Sedláček, R. (2022) · Cells · doi:10.3390/cells11182815 · Cited by 18
Roy, B., Amemasor, E., Hussain, S., & Castro, K. (2023) · Diseases · doi:10.3390/diseases12010007 · Cited by 17
Moreira-de-Sá, A., Gonçalves, F. Q., Lopes, J. P., Silva, H. B. L., Tomé, Â. R., Cunha, R. A., & Canas, P. M. (2021) · Molecular Neurobiology · doi:10.1007/s12035-020-02275-9 · Cited by 16
Circadian Rhythms and Sleep Are Dependent Upon Expression Levels of Key Ubiquitin Ligase Ube3a
Shi, S.-Q., Mahoney, C. E., Houdek, P., Zhao, W., Anderson, M. P., Zhuo, X., Beaudet, A. L., Sumová, A., Scammell, T. E., & Johnson, C. H. (2022) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2022.837523 · Cited by 14
Minárovits, J., & Niller, H. H. (2012) · Springer eBooks · doi:10.1007/978-1-4614-3345-3 · Cited by 13
Kyllerman, M. (2013) · Handbook of clinical neurology · doi:10.1016/b978-0-444-52891-9.00032-4 · Cited by 13
Cheron, G. A., Márquez‐Ruiz, J., Kishino, T., & Dan, B. (2014) · Frontiers in Systems Neuroscience · doi:10.3389/fnsys.2014.00221 · Cited by 18
The Function of CaM Kinase II in Synaptic Plasticity and Spine Formation
Fukunaga, K., Shioda, N., & Miyamoto, E. (2009) · Springer eBooks · doi:10.1007/978-0-387-30370-3_9 · Cited by 12
Qiu, Z., & Cheng, J. (2010) · Neurosignals · doi:10.1159/000320970 · Cited by 13
Alterations of synaptic plasticity in Angelman syndrome model mice are rescued by 5-HT7R stimulation
Pizzella, A., Penna, E., Liu, Y., Abate, N., Lacivita, E., Leopoldo, M., Perrone‐Capano, C., Crispino, M., Baudry, M., & Bi, X. (2024) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2024.102684 · Cited by 11
Grier, M. D., Carson, R. P., & Lagrange, A. H. (2015) · Behavioural Brain Research · doi:10.1016/j.bbr.2015.05.045 · Cited by 12
Rayi, P. R., Koyavski, L., Chakraborty, D., Bagrov, A. Y., & Kaphzan, H. (2019) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2019.101676 · Cited by 13
Bioinformatics analyses show dysregulation of calcium-related genes in Angelman syndrome mouse model
Panov, J., & Kaphzan, H. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.105180 · Cited by 12
Musi, C. A., Agrò, G., Buccarello, L., Camuso, S., & Borsello, T. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.104812 · Cited by 12
Metadata
- Authors
- van Woerden, G. M., Harris, K. D., Hojjati, M. R., Gustin, R. M., Qiu, S., de Avila Freire, R., Jiang, Y.-H., Elgersma, Y., & Weeber, E. J.
- Affiliations
- Vanderbilt University (US)
- Erasmus MC (NL)
- Baylor College of Medicine (US)
- Corresponding author
- Elgersma, Ype
- Venue
- Nature Neuroscience
- Published
- 2007-01-28
- Volume
- 10
- Issue
- 3
- Pages
- 280-282
- ISSN
- 1097-6256 (ISSN-L)
- 1546-1726
- OpenAlex
- W2149631083
- Cited by
- 281
- References
- 15
- Citations by year
- 2026: 6 · 2025: 3 · 2024: 9 · 2023: 8 · 2022: 9 · 2021: 14 · 2020: 19 · 2019: 14 · 2018: 10 · 2017: 20 · 2016: 11 · 2015: 27 · 2014: 17 · 2013: 19 · 2012: 18
- FWCI
- 9.47
- Type
- journal article
- Language
- en
- Open access
- green
- hdl.handle.net
- Licence
- other-oa
- www.springer.com/tdm (tdm)
- Locations
- Nature Neuroscience (publishedVersion)
- PubMed (publishedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (publishedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (submittedVersion)
- RePub (Erasmus University Rotterdam) (submittedVersion, other-oa)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Syndromes and Imprinting
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- Angelman syndrome, CaMKIIα, inhibitory phosphorylation, mouse model, neurological deficit, intellectual disability, epilepsy, motor impairment
- MeSH terms
- Animals, Behavior, Animal, Mental Disorders, Conditioning, Classical, Disease Models, Animal, Female, Hippocampus, Male, Mice, Inbred C57BL, Mice, Neurologic Mutants, Motor Activity, Phosphorylation, Phosphotransferases, Reaction Time, Time Factors, Angelman Syndrome, Maze Learning, Excitatory Postsynaptic Potentials, Ubiquitin-Protein Ligases, Freezing Reaction, Cataleptic, Mice, Calcium-Calmodulin-Dependent Protein Kinase Type 2, In Vitro Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.